| Authors: |
You B; Université Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon-Sud, EMR UCBL/HCL 3738, Lyon, France GINECO, Paris, France.; Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), CITOHL, GINECO-GINEGEPS, Lyon, France., Purdy C; Clinical Trial Development Division, Biostatistics and Bioinformatics Department, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Copeland LJ; The Ohio State University, James Cancer Hospital, Columbus, OH., Swisher EM; Division of Gynecologic Oncology, Department of Ob/Gyn, University of Washington, Seattle, WA., Bookman MA; Director, Gynecologic Oncology Therapeutics, Kaiser Permanente Northern California, San Francisco, CA., Fleming G; Hematology and Oncology, The University of Chicago Medicine, Chicago, IL., Coleman R; Chief Scientific Officer, US Oncology Research, The Woodlands, TX., Randall LM; Division of Gynecologic Oncology, Virginia Commonwealth University, School of Medicine, Richmond, VA., Tewari KS; UC Irvine Medical Center, Orange, CA., Monk BJ; HonorHealth Research Institute, University of Arizona, Creighton University, Phoenix, AZ., Mannel RS; The University of Oklahoma, Oklahoma City, OK., Walker JL; The University of Oklahoma, Oklahoma City, OK., Cappuccini F; UC Irvine Medical Center, Orange, CA., Cohn D; The Ohio State University, James Cancer Hospital, Columbus, OH., Muzaffar M; Internal Medicine, East Carolina University, Greenville, NC., Mutch D; Washington University School of Medicine, Siteman Cancer Center, St Louis, MO., Wahner-Hendrickson A; Division of Medical Oncology, Mayo Clinic, Rochester, MN., Martin L; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA.; Mersana Therapeutics, Cambridge, MA., Colomban O; Université Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon-Sud, EMR UCBL/HCL 3738, Lyon, France GINECO, Paris, France.; Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), CITOHL, GINECO-GINEGEPS, Lyon, France., Burger RA; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA.; Mersana Therapeutics, Cambridge, MA. |
